In October 2022, the FDA granted fast-track designation for tirzepatide, the active ingredient in Mounjaro, for the treatment of obesity or overweight with weight-related medical conditions
So is it fixing something that in some people, for whatever reason we don't understand, that signaling is not working the way it's supposed to
Join over 50,000 patients who trust Hi-Doctor, reflected in our 4.8 Trustpilot rating
I dont want patients thinking a medication will solve everything
Ozempic: the truth about new weight loss drugs What to do about fake weight-loss drugs and compounded versions Nutrition is vital when taking GLP-1 weight-loss drugs
Always check the expiry date printed on the packaging before use and do not use the product if it has passed its expiration date